{"url_path":"/sec/invx/8-k/2026-07-01/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1042893/0001193125-26-292774-index.html","accession_number":"0001193125-26-292774","cik":"0001042893","ticker":"INVX","issuer_name":"Innovex International, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1042893/0001193125-26-292774-index.html","primary_entity_key":"0001042893","primary_entity_name":"Innovex International, Inc."},"word_count":157,"has_tables":true,"body_markdown":"Item 3.02\n\nUnregistered Sales of Equity Securities.\n\n \n\nThe information set forth in Item 3.02 of the Original Form 8-K is hereby supplemented as follows:\n\n \n\nOn July 1, 2026, the Company closed the Transaction and issued 1,060,713 shares of Common Stock to the seller as merger consideration. The number of shares issued was determined based on the average of the volume weighted average trading prices of the Common Stock on the New York Stock Exchange over the fifteen trading days immediately preceding June 15, 2026. The issuance of shares of Common Stock is exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof.\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\n \n\n \n\nInnovex International, Inc.\n\n \n\n \n\nDate: July 1, 2026\n\nBy:\n\n/s/ Adam Anderson\n\n \n\nAdam Anderson\n\n \n\nChief Executive Officer"}